Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
Science
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients
Work with us – your premier oncology partner – to optimize cancer care for patients